Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance
- PMID:18329487
- DOI: 10.1016/j.jtcvs.2007.09.014
Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance
Abstract
Objective: Controversies regarding the safety, morbidity, and mortality of thoracoscopic lobectomy have prevented the widespread acceptance of the procedure. This series analyzed the safety, pain, analgesic use, and discharge disposition in patients who underwent thoracoscopic lobectomy and segmentectomy at a single institution.
Methods: We collected data from 153 consecutive patients who underwent thoracoscopic (video-assisted thoracic surgery) lobectomy and assessed the perioperative outcomes, postoperative pain, and chemotherapy course. A total of 111 of 127 patients with lung cancer had stage I non-small cell lung cancer. The operative technique required 2 ports and an access incision (5-8 cm), individual hilar ligation, and lymph node dissection performed without rib-spreading devices.
Results: There were 9 major complications (6%), including 1 perioperative death (0.7%). Conversion to thoracotomy occurred in 14 patients (9.2%). Blood transfusion was required in 11 patients (7%). The median chest tube time was 3 days, and the length of hospital stay was 4 days; 94.4% of patients went home at the time of discharge, and 5.6% of patients required a rehabilitation facility. At a median postsurgical follow-up time of 2 weeks, the mean postoperative pain score was 0.6 (0-3), 73% of patients did not use narcotics for pain control, and 47% of patients did not use any pain medication. Of patients receiving chemotherapy (N = 26), 73% completed a full course on schedule and 85% received all intended cycles.
Conclusion: Thoracoscopic (video-assisted thoracic surgery) lobectomy can be performed safely. Discharge independence and low pain estimates in the early postoperative period suggest that this approach may be beneficial. Furthermore, there is a trend toward improved tolerance of chemotherapy.
Similar articles
- The safe transition from open to thoracoscopic lobectomy: a 5-year experience.Seder CW, Hanna K, Lucia V, Boura J, Kim SW, Welsh RJ, Chmielewski GW.Seder CW, et al.Ann Thorac Surg. 2009 Jul;88(1):216-25; discussion 225-6. doi: 10.1016/j.athoracsur.2009.04.017.Ann Thorac Surg. 2009.PMID:19559229
- Video-assisted thoracoscopic surgery segmentectomy: a safe and effective procedure.Leshnower BG, Miller DL, Fernandez FG, Pickens A, Force SD.Leshnower BG, et al.Ann Thorac Surg. 2010 May;89(5):1571-6. doi: 10.1016/j.athoracsur.2010.01.061.Ann Thorac Surg. 2010.PMID:20417779
- Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.Whitson BA, D'Cunha J, Andrade RS, Kelly RF, Groth SS, Wu B, Miller JS, Kratzke RA, Maddaus MA.Whitson BA, et al.Ann Thorac Surg. 2008 Dec;86(6):1735-44. doi: 10.1016/j.athoracsur.2008.07.001.Ann Thorac Surg. 2008.PMID:19021967
- Video-assisted thoracoscopic lobectomy: state of the art and future directions.Shaw JP, Dembitzer FR, Wisnivesky JP, Litle VR, Weiser TS, Yun J, Chin C, Swanson SJ.Shaw JP, et al.Ann Thorac Surg. 2008 Feb;85(2):S705-9. doi: 10.1016/j.athoracsur.2007.11.048.Ann Thorac Surg. 2008.PMID:18222201Review.
- Video-assisted thoracic surgery lobectomy (VATS), open thoracotomy, and the robot for lung cancer.Flores RM, Alam N.Flores RM, et al.Ann Thorac Surg. 2008 Feb;85(2):S710-5. doi: 10.1016/j.athoracsur.2007.09.055.Ann Thorac Surg. 2008.PMID:18222202Review.
Cited by
- Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer.Villamizar NR, Darrabie M, Hanna J, Onaitis MW, Tong BC, D'Amico TA, Berry MF.Villamizar NR, et al.J Thorac Cardiovasc Surg. 2013 Feb;145(2):514-20; discussion 520-1. doi: 10.1016/j.jtcvs.2012.10.039. Epub 2012 Nov 21.J Thorac Cardiovasc Surg. 2013.PMID:23177123Free PMC article.
- Video-assisted thoracoscopic surgery versus open thoracotomy in the management of empyema: A comparative study.Jindal R, Nar AS, Mishra A, Singh RP, Aggarwal A, Bansal N.Jindal R, et al.J Minim Access Surg. 2021 Oct-Dec;17(4):470-478. doi: 10.4103/jmas.JMAS_249_19.J Minim Access Surg. 2021.PMID:33047681Free PMC article.
- Feasibility Of Administering Adjuvant Chemotherapy Of Pemetrexed Followed By Pemetrexed/oxaliplatin Immediately Post-VATS In Patients With Completely Resected NSCLC.He J, Shao W, Li S, Chen M, Chen H, Liu J, Wang W, Qiu Y, Wang D.He J, et al.J Thorac Dis. 2009 Dec;1(1):55-62.J Thorac Dis. 2009.PMID:22263005Free PMC article.
- Predictive factors of postoperative complications in single-port video-assisted thoracoscopic anatomical resection: Two center experience.Gonzalez-Rivas D, Kuo YC, Wu CY, Delgado M, Mercedes T, Fernandez R, Fieira E, Hsieh MJ, Paradela M, Chao YK, Wu CF.Gonzalez-Rivas D, et al.Medicine (Baltimore). 2018 Oct;97(40):e12664. doi: 10.1097/MD.0000000000012664.Medicine (Baltimore). 2018.PMID:30290649Free PMC article.
- Lymph node upstaging for non-small cell lung cancer after uniportal video-assisted thoracoscopy.Ismail M, Nachira D, Swierzy M, Ferretti GM, Englisch JP, Ossami Saidy RR, Li F, Badakhshi H, Rueckert JC.Ismail M, et al.J Thorac Dis. 2018 Nov;10(Suppl 31):S3648-S3654. doi: 10.21037/jtd.2018.06.70.J Thorac Dis. 2018.PMID:30505548Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical